Unlocking the Potential of Adequate Bacillus Calmette-Guérin Immunotherapy in Very-high-risk Non–muscle-invasive Bladder Carcinoma: A Multicenter Analysis of Oncological Outcomes and Risk Dynamics-Reference-Cited by-同舟云学术

Unlocking the Potential of Adequate Bacillus Calmette-Guérin Immunotherapy in Very-high-risk Non–muscle-invasive Bladder Carcinoma: A Multicenter Analysis of Oncological Outcomes and Risk Dynamics

Published:2024-02 Issue: Volume: Page:
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Subiela José Daniel,Krajewski Wojciech,González-Padilla Daniel A.,Laszkiewicz Jan,Taborda Javier,Aumatell Júlia,Sanchez Encinas Miguel,Basile Giuseppe,Moschini Marco,Caño-Velasco Jorge,Lopez Perez Enrique,Del Olmo Durán Pedro,Gallioli Andrea,Tukiendorf Andrzej,D'Andrea David,Yuen-Chun Teoh Jeremy,Serna Céspedes Alejandra,Pichler Renate,Afferi Luca,Del Giudice Francesco,Gomez Rivas Juan,Albisinni Simone,Soria Francesco,Ploussard Guillaume,Mertens Laura S.,Rajwa Paweł,Laukhtina Ekaterina,Pradere Benjamin,Tully Karl,Guerrero-Ramos Félix,Rodríguez-Faba Óscar,Alvarez-Maestro Mario,Dominguez-Escrig Jose Luis,Szydełko Tomasz,Gomez Dos Santos Victoria,Jiménez Cidre Miguel Ángel,Burgos Revilla Francisco Javier

Publisher

Elsevier BV

Reference17 articles.

1. European Association of Urology (EAU) prognostic factor risk groups for non-muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC Guidelines Panel;Sylvester;Eur Urol,2021

2. European Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ);Babjuk;Eur Urol,2022

3. Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high-grade non-muscle-invasive urothelial bladder cancer;Krajewski;Urol Oncol,2022

4. Updated European Association of Urology (EAU) prognostic factor risk groups overestimate the risk of progression in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guerin;Lobo;Eur Urol Oncol,2022

5. Balancing protection and free movement of personal data: the New European Union General Data Protection Regulation;Bentzen;Ann Intern Med,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association Between Residual Urine Volume and Recurrence Among Patients at High Risk of Non-Muscle-Invasive Bladder Carcinoma With Versus Without Bacillus Calmette-Guérin Treatment;Cureus;2024-05-30

2. Implementación de los nuevos tratamientos para el tumor vesical no músculo invasivo que no responde al tratamiento con BCG. Aspectos a considerar en Latinoamérica;Actas Urológicas Españolas;2024-05

3. Implementation of new treatments for BCG-unresponsive non-muscle-invasive bladder cancer. Considerations in Latin America;Actas Urológicas Españolas (English Edition);2024-05